Foley Partner Jon Dudas, former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO), will be presenting on “Appealing Beyond the Supreme Court: Patent Reform Legislation” as part of the BrightTALK’s Web conference program on October 8, 2009.
With litigation costs and awards significantly increasing, many are seeking answers outside of the courtroom. Controversial legislation to revamp the law of damages, challenges to patents outside the court, venue and more is held up again in Congress. If passed, the legislation could mean dramatic changes to your business model and patent strategies.
For more information or to register, please visit the BrightTALK Web site.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.